NewAmsterdam Pharma Company N.V. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3.0M | 32K | 348K | 19.1M | 3.0M | 12.8M | 29.1M | 2.3M |
| Cost of Goods Sold | 500K | 59K | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 2.5M | -27K | 348K | 19.1M | 3.0M | 12.8M | 29.1M | 2.3M |
| R&D Expenses | 37.5M | 38.6M | 31.0M | 27.5M | 44.8M | 34.9M | 35.7M | 38.4M |
| Operating Expenses | 61.0M | 66.0M | 55.5M | 54.8M | 71.9M | 56.0M | 54.1M | 54.9M |
| Operating Income | -58.4M | -66.0M | -55.1M | -35.6M | -68.9M | -43.2M | -25.0M | -52.6M |
| Other Income / Gains | 10.0M | -8.9M | -16.9M | 18.3M | 29.4M | -48.9M | 8.4M | 13.6M |
| Net Income | -48.4M | -74.9M | -72.0M | -17.4M | -39.5M | -92.2M | -16.6M | -39.0M |
| EPS (Diluted) | -0.40 | -0.65 | -0.61 | -0.15 | -0.34 | -0.98 | -0.18 | -0.41 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.836 | -0.844 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| General And Administrative Expenses | 23.4M | 27.4M | 24.5M | 27.3M | 27.2M | 35.5M | 13.7M | 11.8M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | -11.1M | 3.5M | 3.5M |
| Selling General And Administrative Expenses | 23.4M | 27.4M | 24.5M | 27.3M | 27.2M | 24.3M | 17.3M | 15.3M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | -3.2M | 1.1M | 1.2M |
| Cost And Expenses | 61.5M | 66.0M | 55.5M | 54.8M | 71.9M | 56.0M | 54.1M | 54.9M |
| Interest Income | 4.0M | 6.5M | 6.7M | 7.1M | 7.4M | 4.5M | 4.4M | 4.9M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 62K | 59K | 64K | 45K | 52K | 51K | 28K | 19K |
| Ebitda | -58.4M | -65.9M | -71.9M | -35.6M | -68.9M | -111.7M | -23.8M | -51.4M |
| Ebitdaratio | -19.197 | -2K | -206.727 | -1.859 | -23.127 | -8.745 | -0.819 | -22.545 |
| Operating Income Ratio | -19.217 | -2K | -158.457 | -1.861 | -23.145 | -3.385 | -0.859 | -23.069 |
| Income Before Tax | -48.4M | -74.9M | -72.0M | -17.4M | -39.5M | -92.2M | -16.6M | -39.0M |
| Income Before Tax Ratio | -15.935 | -2K | -206.911 | -0.907 | -13.273 | -7.217 | -0.572 | -17.116 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | -1K | 0 |
| Net Income Ratio | -15.935 | -2K | -206.911 | -0.907 | -13.273 | -7.217 | -0.572 | -17.116 |
| Epsdiluted | -0.40 | -0.65 | -0.61 | -0.15 | -0.34 | -0.98 | -0.18 | -0.41 |
| Weighted Average Shs Out | 121.1M | 114.4M | 119.0M | 112.5M | 116.1M | 97.0M | 94.8M | 94.7M |
| Weighted Average Shs Out Dil | 121.1M | 114.4M | 119.0M | 112.5M | 116.1M | 97.0M | 94.8M | 94.7M |